#Budapest #Hungary #Gedeon Richter #Endometriosis #SEUD Congress

Gedeon Richter's Advances in Endometriosis Treatment

The SEUD (Society of Endometriosis and Uterine Disorders) Congress held from April 24 to 26, 2025, in Prague became a focal point for discussions on modern medical treatments for endometriosis. This crucial meeting attracted renowned international experts and hundreds of attendees who participated in a successful symposium supported by Gedeon Richter. Notable presentations were given by leading specialists, including Professor Charles Chapron from France, Dr. Harald Krentel from Germany, Dr. Stavros Karampelas from Belgium, and Dr. Silvia Vannuccini from Italy.

Understanding Endometriosis

Endometriosis is a chronic and painful condition affecting over 190 million women globally. The disease is characterized by the growth of tissue similar to the uterine lining outside the uterus, leading to inflammation, scarring, and intense pain. This condition not only imposes severe physical discomfort but also significantly impacts fertility and overall quality of life. Alarmingly, affected women often wait between seven to nine years for an accurate diagnosis and timely treatment.

Historically, surgical intervention was the mainstay for treating endometriosis. However, there has been a significant shift towards medical therapy, which is becoming the preferred choice due to its less invasive nature and long-term effectiveness. Hormonal treatments aim to lower estrogen levels, consequently slowing the growth of endometrial-like tissue. Clinical studies have shown that more than 70% of women undergoing hormonal therapy experience significant pain reduction and improved quality of life.

Gedeon Richter's Revolutionary Treatment

Gedeon Richter has pioneered the world's first combined therapy using GnRH antagonists for the treatment of both symptomatic endometriosis and uterine fibroids. This innovative medication leverages multiple active ingredients to efficiently target the underlying mechanisms of the disease, offering rapid and lasting relief from symptoms through a single daily oral administration. Its verified safety, comfort, and efficacy empower countless women to manage their conditions effectively without resorting to surgery.

As stated by Péter Turek, the head of Gedeon Richter’s Women’s Health Business Unit, "As a leading pharmaceutical company in Europe focusing on women's health, we are committed to offering modern and innovative solutions worldwide. We believe that continual advancement in therapeutic options, such as our endometriosis medication, is essential for improving the quality of life for millions of women globally."

While surgery remains crucial for severe cases, it carries significant risks, including a 30-50% chance of symptom recurrence within five years. In contrast, modern pharmacological treatments provide a safer and more sustainable approach to managing the disease, allowing women to maintain their health and quality of life.

Thanks to Gedeon Richter's innovative therapeutic solutions, millions of women battling endometriosis now have renewed hope. Today, effectively controlling symptoms without invasive procedures is a tangible reality, empowering women to lead fulfilling, pain-free lives.

About Gedeon Richter

Gedeon Richter is committed to pioneering advancements in women's health, continuously striving to enhance therapeutic options available for conditions like endometriosis.

Through education, research, and commitment to patient well-being, they aim to transform the lives of women affected by reproductive health issues across the globe.

This shift not only includes medication but also comprehensive support and education around endometriosis, helping women make informed choices about their health.

Conclusion
The SEUD Congress served as a reminder of the importance of modern medical interventions for conditions like endometriosis. Through contributions from companies like Gedeon Richter, progress continues toward a world where women can manage their health with effective, innovative treatments.